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Expression of Amino-Terminally Truncated PrP
in the Mouse Leading to Ataxia
and Specific Cerebellar Lesions
normally and showed no obvious pathological pheno-
type (BuÈ eler et al., 1992; Manson et al., 1994; Sakaguchi
et al., 1995). Electrophysiological abnormalities in the
brains of such knockout mice have been reported by
one group (Collinge et al., 1994; Whittington et al., 1995;
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Christian von Mering,* Christoph Hangartner,*
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Colling et al., 1996) but not by others (Herms et al., 1995;* Institut fuÈ r Molekularbiologie
Lledo et al., 1996) in the same line of mice. An alterationAbteilung I
in circadian activity rhythms of these mice has beenUniversitaÈ t ZuÈ rich
described (Tobler et al., 1996).8093 ZuÈ rich
Sakaguchi et al. developed a line of PrP knockoutSwitzerland
mice in which, in addition to the coding sequence, about²Institut fuÈ r Neuropathologie
900 bp of the second intron and 450 bp of the 39 noncod-³Biologisches Zentrallabor
ing sequence of the PrP gene were deleted (SakaguchiUniversitaÈ tsspital ZuÈ rich
et al., 1995). These mice also developed normally, but8091 ZuÈ rich
at about 70 weeks of age showed progressive symp-Switzerland
toms of ataxia and an extensive loss of Purkinje cells
in thecerebellum (Sakaguchi et al., 1996).Because these
symptoms were not observed in the other PrP knockoutSummary
lines, they were likely not due to deletion of the PrP
coding region (Weissmann, 1996).The physiological role of prion protein (PrP) remains
Common to all PrP knockout mice is resistance tounknown. Mice devoid of PrP develop normally but are
scrapie and inability to propagate the scrapie agent, orresistant to scrapie; introduction of a PrP transgene
prion, as predicted by the ªprotein onlyº hypothesis.restores susceptibility to the disease. To identify the
There is no obvious clue as to the physiological role ofregions of PrP necessary for this activity, we prepared
PrP other than that it binds copper (Brown et al., 1997)PrP knockout mice expressing PrPs with amino-proxi-
and that it is located at the outer cell surface, suggestingmal deletions. Surprisingly, PrP lacking residues 32±
a role as transporter, ligand, or receptor.121 or 32±134, but not with shorter deletions, caused
We have undertaken a study of the structure±activitysevere ataxia and neuronal death limited to the granu-
relationship of PrP regarding its capacity to supportlar layer of the cerebellum as early as 1±3 months
scrapie pathogenesis and prion propagation. In our first
after birth. The defect was completely abolished by
report, we showed that in PrP knockout mice overex-
introducing one copy of a wild-type PrP gene. We
pression of recombinant PrP genes with deletions from
speculate that these truncated PrPs may be nonfunc-
codons 69 to 84 or from 32 to 80 was able to restore
tional and compete with some other molecule with a these functions (Fischer et al., 1996). We then prepared a
PrP-like function for a common ligand. series of deletions extending further toward the carboxyl
terminus. Unexpectedly, expression at moderate levels
Introduction of PrP molecules with deletions from codons 32 to 121
or 134 but not with the shorter deletions 32±80, 32±93,
PrPSc, a protein pathognomonic for transmissible spon- or 32±106 caused ataxia and specific degeneration of
giform encephalopathies (Prusiner, 1982), is a modified the granular layer of the cerebellum within 2±3 months
form of PrPC (Oesch et al., 1985). PrPC is expressed in after birth. The defect was completely abrogated if one
all vertebrates examined, mainly in the brain but also in or more copies of a wild-type murine PrP gene were
many other tissues at lower levels (Bendheim et al., introduced into mice carrying multiple copies of the trun-
1992). It is encoded by a single exon of a unique gene, cated gene. We speculate that the truncated PrP may
synthesized as a precursor protein, and processed into compete with some other molecule with a similar func-
a mature form by removal of its amino terminal signal tion as PrP for a common ligand.
sequence, glycosylation, and replacement of its car-
boxy-terminal signal sequence by a GPI residue, which Results
anchors it to the outer cell surface.
Three lines of mice devoid of PrPC have been gener- Characterization of Transgenic Mice
atedby homologousrecombination using different strat- Expressing Truncated PrP
egies (BuÈ eler et al., 1992; Manson et al.,1994; Sakaguchi Fischer et al. developed a PrP-encoding vector based
et al., 1995). In two of the lines, the mice developed on the murine PrP gene (Figure 1A) from which the large
intron had been deleted and that contained 6 kb of
59 and 2.2 kb of 39 flanking sequence (ªhalf-genomic
§To whom correspondence should be addressed. constructº or pPrPHG [Figure 1B; Fischer et al., 1996]).‖ Present address: Core Technologies Department, Novartis Pharma
This vector, which contains the wild-type PrP sequence,AG, 4002 Basel, Switzerland.
restored susceptibility to scrapie in a dose-dependent# Present address: Department fuÈ r Innere Medizin, Abteilung fuÈ r
manner when introduced into Prnpo/o mice. It was subse-Infektionskrankheiten, UniversitaÈ tsspital ZuÈ rich, 8091 ZuÈ rich, Swit-
zerland. quently found that even in transgenic mice showing
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Figure 1. PrP Genes, Transgenes, and Transgenic Mice
(A) Map of the murine PrP gene. The horizontal arrows indicate primers used for various purposes.
(B) Map of the PrP expression vector pPrPHG and the restriction sites and primers used for the construction of the PrP deletion plasmids.
(C) Maps of the exon 2/3 regions of wild-type and truncated PrP expression plasmids and characterization of the PrP transgenic mice.
Constructs A and B and the cognate transgenic mice were described earlier (Fischer, 1995) as PrPDNco and PrPDN-term, respectively. Gene
copy number, PrP mRNA, and PrP levels are given relative to wild type and were determined as described in Experimental Procedures.
several-fold higher expression of PrP in brain than wild- In preparing amino-proximal deletions of PrP, we re-
tained the sequences encoding the amino-terminal sig-type mice, there was no detectable PrP mRNA in Pur-
kinje cells, suggesting that there might be a Purkinje nal sequence and the adjoining nine amino acids to
ensure transport into the endoplasmic reticulum andcell±specific enhancer in the large intron or in a segment
of 39 flanking region absent in the construct (Fischer et proper processing. Because deletion of residues 32±80
did not abolish the capacity of PrP to support scrapieal., 1996).
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pathogenesis and prion replication, we prepared a se-
ries of deletions extending further towards the carboxyl
terminus (Figure 1C). The appropriate constructs were
injected into the pronuclei of Prnpo/o zygotes, and trans-
gene-carrying animals were identified and bred to Prnpo/o
mice. In two cases (C15 and D32), injection was into
wild-type embryos, and the transgeneswere then crossed
into Prnpo/o mice. The resulting populations, which had
a mixed 129/Sv-C57BL/6 background, were analyzed in
regard to the gene copy number as well as PrP mRNA
and PrP levels (Figure 1C). PrP levels were estimated
by quantitation of Western blots of glycosylated as well
as deglycosylated brain samples relative to wild type
(Figure 2B). Because the PrP molecules had deletions
of various lengths, it was necessary to ascertain that
the antibody gave a commensurate signal for the differ-
ent PrP species. This was the case within 6 20% for
wild-type PrP and PrP with deletions 32±80 and 32±121
(Figure 2C).
Surprisingly, the mobilities of the major species of PrP
molecules with deletions extending to positions 93 (type
C), 106 (type D), 121 (type E), and 134 (type F) did not
differ noticeably on SDS-polyacrylamide gels (Figure
2B), but they were greater than those of wild-type PrP.
There were, however, faster-running minor bands whose
mobility showed the expected increase with increasing
deletion size (constructs B, C, D, and E). Because these
might represent unglycosylated species, we suspected
that the aberrant mobilities might be due to the carbohy-
drate residues and subjected all samples to PNGase
digestion. As shown in Figure 2B, this indeed resulted
in major PrP bands showing increasing mobility with
increasing deletions. In addition, all samples showed a
fast-running band with a mobility corresponding to a
molecular weight of about 20,000, at varying intensities.
Because the band had the same mobility for the different
deletion mutants, we conclude that it is a carboxy-termi-
nal PrP fragment resulting from proteolytic digestion.
This cleavage likely occurs at least in part in vivo be-
cause extraction under different conditions and in the
presence of protease inhibitors did not reproducibly re-
duce the intensity of the band (data not shown) and
because such cleavages have been described pre-
viously in preparations from brain or from cell culture
(Harris et al., 1993; Chen et al., 1995). The origin of this
fragment was not further investigated.
Wild-type and truncated D32±134 PrP, as expressed
in permanently transformed 911 cells, were present at
Figure 2. Analysis of Brain Tissue of Transgenic Mice Expressingthe cell surface, as evidenced by cell surface staining
Truncated PrP and of Wild-Type Mice
with PrP antibodies and examination by confocal mi-
(A) Northern analysis of total brain RNA using a PrP mRNA probecroscopy (data not shown).
(top panel) and, after stripping, a GAPDH probe (bottom panel).
(B) Western analysis using PrP antiserum R340 on untreated (top
panel) and deglycosylated (PNGase F-treated; bottom panel) brain
The Phenotype of Mice Expressing protein.
Truncated PrP (C) Western analysis of truncated PrP from E. coli (320 ng/lane) to
show that antibodies R009 (middle panel) and R340 (right panel)Surprisingly, mice overexpressing PrP with deletions
interact about equally well with all forms of truncated PrP. The left32±121 (type E) and 32±134 (type F) (Figure 1C) devel-
panel shows a Coomassie blue±stained gel loaded with 4 mg proteinoped pronounced behavioral disorders between 3 and
per lane.
8 weeks of age. The earliest features were coarse tremor (D) Coexpression of wild-type and truncated PrP in brains of F1
and staggering gait (Figure 3A) followed by paresis of mice derived from an F11/2, Prnp1/o 3 F11/2, Prnp1/o cross (left
the hind legs; the animals then found it difficult or were panel) and an E11/2, Prnpo/o 3 tga20/2 cross (right panel). Each
lane was loaded with 50 mg total brain protein.unable to right themselves when laid on their sides or
Cell
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Figure 3. Footprints of PrP Knockout Mice without the PrnpD32±134 Gene Cluster
The posterior footpads of a 12-week-old F35 mouse and of a Prnpo/o littermate were dipped in India ink and the mice were allowed to walk
on a sheet of paper. Footprints of the F35 mouse (A) and the control Prnpo/o mouse (B). (C) The F35 mouse is droopy due to low tonus and
has bedraggled fur, perhaps because of deficient grooming. (D) An alert and happy control mouse. Both mice are 12 weeks old.
backs. The mice were underweight and lost weight as the white matter of the pons (Figure 4G). Strikingly, the
Purkinje cells appeared normal (Figure 4I), and the mo-they aged; at 14 weeks wild-type and F11 animals
weighed 25.3 6 1.4 g (n 5 6) and 15.8 6 2.0 g (n 5 5), lecular layer was only modestly reduced in width and
still contained a high density of Purkinje cell dendritesrespectively, and moribund animals weighed 12.1 6 2.1
g (12±25 weeks of age; n 5 4). The F11 mice appeared (Figures 5E and 5F; MAP2). Luxol-Nissl stainings did not
disclose evidence of myelin breakdown (Figures 5G andto be weak and more susceptible to parasitic infection,
perhaps because of insufficient grooming. Ultimately, 5H; LN) despite massive vacuolation of myelinated fiber
tracts in the brain stem of some mice. The remainderthe mice were severely handicapped in their movements
and had to be sacrificed. F35 mice, which had the higher of the brain showed no obvious changes except for
occasional patchy astrocytosis, which was also ob-D32±134 transgene copy number (Figure 1C), were the
earliest to show symptoms (3±4 weeks after birth) and served in wild-type litter mates. E11 mice, in addition
to these findings, showed severe vacuolation in thebraindeteriorated the most rapidly, having to be sacrificed at
2±3 months of age. These mice rarely bred spontane- stem, particularly in the intracerebral portion of the cra-
nial nerves. There was some variation in the severity ofously and initially were mostly propagated by mating a
superovulated F35 female with a normal Prnpo/o male the phenotype among individual mice, and one mouse
aged 22 weeks displayed only marginal granule cell layerand transferring the embryos into healthy fosters or, on
occasion, by in vitro fertilization using testicular sperm loss despite pronounced cerebellar gliosis. The mice
with the shorter truncations of PrP, up to residue 106,from a transgenic animal. Currently, F35 mice are being
maintained as heterozygotes containing the F35 trans- show no pathological changes (Figures 4B and 4C).
Expression of PrP in the brain of E11 and F11 micegene cluster on a Prnp1/o background because, as de-
scribed below, these mice show no impairment and the aged 3±10 weeks (Figures 6A±6F) was studied by immu-
nohistochemistry. Expression was widespread, encom-pathological phenotype can be recovered by crossing
with Prnpo/o mice. passed both forebrain and cerebellum, and was roughly
similar in all mice analyzed as judged by staining inten-Histological examination of the brains of 2±3 month±
old animals showed that E11, F11, and F35 but not C4 sity. No significant modulation of PrP expression was
detected during the time period analyzed. PrP was ex-or D32 mice had massive pathological changes in the
cerebellum: a dramatic reduction in the width of the pressed in all layers of the cerebellum except for the
Purkinje cells (Figure 4I). Histoblot analysis failed to re-granular cell layer in the hemispheres (Figures 4A±4F)
and vermis but not the flocculus (Figures 4G and 4H), veal protease-resistant PrP and no birefringent deposits
could be observed after Congo red staining (data notintense astrocytosis affecting in particular the Berg-
mann glia, and irregularly distributed large vacuoles in shown).
Pathogenic Effect of Truncated PrP
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Figure 4. Neuropathology of Transgenic Mice with Amino-Proximal Deletions of Prion Protein
(A±F) Comparison of GFAP immunostains of the cerebellar cortex of various transgenic and wild-type mice. Cerebella of transgenic mice C4
([B], 8 weeks old) and D32 ([C], 10 weeks old) are histologically normal and indistinguishable from those of wild-type mice (A). Transgenic
lines E11 ([D], 8 weeks old), F11 ([E], 25 weeks old), and F35 ([F], 6 weeks old) show a striking reduction of the internal granular layer of the
cerebellum and intense astrocytic gliosis.
(G±H) GFAP-stained sections through the cerebellum of E11 ([G], 10 weeks old) and F11 ([H], 12 weeks old) transgenic mice. Prominent
astrogliosis and neuronal loss in the internal granular layer, as well as white matter spongiosis, affect the entire cerebellum except for the
flocculus (Fl), which is largely unaffected. Pfl, paraflocculus.
(I) At higher magnification, PrP-immunostained sections of the cerebellar cortex of F11 transgenic mice (12 weeks old) reveal strong PrP
expression in residual granule cells but no PrP expression in Purkinje cells (PC, arrows). Purkinje cells display no histopathological changes.
(J) Transmission electron microscopy of cerebellar granule cells of F11 transgenic mouse aged 3.5 weeks. Some neuronal cells do not display
ultrastructural changes (asterisk), while others are undergoing apoptosis (plus).
TUNEL analysis yielded strong signals in nuclei of Furthermore, electron microscopy of the cerebellar
granule cell layer (Figure 4J) revealed large numbers ofdegenerating cerebellar granule cells (data not shown)
in parallel to detection of nuclear fragmentation and apoptotic bodies in 3-week-old F11 mice and moderate
numbers in 10- and 16-week-old F11 mice. No sign ofcondensation in transmission electron microscopy (Fig-
ure 4J). No TUNEL positivity and no morphological evi- degeneration in neurons of the pyramidal layer and of
the dentate gyrus in the hippocampus of the same micedence of apoptosis was apparent in other regions of the
central nervous system. were detected in any transgenic line. Also, we were not
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Figure 5. Comparison of Cerebellar Sections
from Prnpo/o and F11 Mice
Sections were stained for PrP (A and B),
GFAP (C and D), microtubule-associated pro-
tein (MAP-2, [E and F]), and Luxol-Nissl (LN,
[G and H]). Both Prnpo/o and F11 mice were
12 weeks old. In contrast to the severely dam-
aged granular cell layer, the molecular layer
shows only a modest reduction in width (C
and D) and no obvious changes in the density
of Purkinje cell dendrites (E and F). The white
matter of F11 mice displaysno signs of myelin
breakdown (G and H).
able to identify intraneuronal inclusion bodies such as represents a reaction to toxic metabolites released dur-
ing the ongoing damage to the cerebellum rather thanthose described by Muramoto et al. (1997) in either cere-
bellar or hippocampal neurons. an intrinsic cortical pathology.
The time course of the pathological changes was ex-
amined in F11 mice (Figures 7B±7F). Astrocytosis was The Cerebellar Defects Are Abrogated
by the Introduction of One or Morebarely apparent at 3 weeks but pronounced at 4 weeks;
individual neurons seemed to be surrounded by astro- Wild-Type PrP Genes
E11, F11, or F35 mice were crossed with mice carryingcytic processes (satellitosis).By 5 weeks pycnotic nuclei
dotted the granular layer, which still had the normal wild-type PrP alleles or tga20 mice carrying a cluster of
wild-type PrP-encoding transgenes. All resulting prog-width; astrocytosis was intense and extended to the
molecular layer. In 1 of 2 5-week-old mice, we observed eny with truncated transgenes E11 or F11 and a tga20
transgene cluster (Table 1, crosses 1, 5, 6, 7, and 8)ongoing synchronous destruction of the granule cell
layer leading to large cystic defects. At 6 weeks the showed normal behavior and normal brain histology
(Figure 7G) as did progeny with the F11 or the highlygranular layer had narrowed; no cystic areas were pres-
ent, perhaps because resorption of degenerated tissue pathogenic F35 gene cluster and with as few as one
copy of a normal PrP gene (Table 1, crosses 2, 4, andand subsequent shrinkage had taken place. At 8 weeks
there was a dearth of cells in the granular layer, while 9). In a preliminary experiment, it was found that even
a cluster of D32±93 transgenes (C4) abrogated the delete-the Purkinje cell layer appeared unaffected.
In the cerebral hemispheres, neuronal loss was not rious effects of the F11 gene cluster (Table 1, cross 8).
It was possible that expression of wild-type PrP inconspicuous at any time point. However, mild yet signifi-
cant gliosis was detected in the thalamus and cortex of some way prevented expression of the truncated PrP
molecules. Western blots of brain extracts from micesome mice at the height of cerebellar degeneration.
Since gliosis was stationary, we tend to believe that it containing the F11 gene cluster and one or two copies
Pathogenic Effect of Truncated PrP
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Figure 6. PrP Expression in the Brains of F11 and E11 Transgenic Mice at Various Ages
Coronal sections (left, forebrain; right, cerebellum) of 3-week- (A), 4-week- (B), 6-week- (C), and 12-week-old F11 mice (D); 8-week- (E), and
10-week-old E11 mice (F); 10-week-old wild-type mice (G); and 12-week-old Prnpo/o mice (H). While strong PrP immunoreactivity is discernible
in brain sections of mice expressing wild-type and mutant PrP proteins, virtually no staining is seen in Prnpo/o tissue. Truncated PrP is
expressed to similar extents in cerebral and cerebellar cortex in E11 or F11 transgenic mice, but pathological changes are found only in the
cerebellum.
of the wild-type Prnp allele, however, showed that the Discussion
level of the truncated PrP was the same as in the ab-
sence of wild-type PrP (Figure 2D, left panel). The same We have found that PrP-null mice expressing at a mod-
erate level transgenes encoding PrP with an amino-ter-was true for the E11 (Figure 2D, right panel) or F11
(not shown) gene cluster in the presence of the tga20 minal deletion extending from residue 32 to 121 or 134,
but not those with the deletions 32±80, 32±93 or 32±106,transgenes.
exhibit severe neurological symptomsand degeneration
of the granular layer of the cerebellum at an early age. ItAttempts to Transmit Disease with Brain
is highly unlikely that this phenotype is due to insertionalExtracts from E and F Mice
mutagenesis, not only because it was expressed in miceIt has been reported that PrP-null mice overexpressing
heterozygous for the insertion but also because it wasPrP with a P101L mutation from the cognate transgenes
observed in three independent transgenic populations.spontaneously develop scrapie-like disease. This dis-
We therefore attribute the phenotype to the expressionease could be transmitted by inoculation of brain ex-
of specific forms of truncated PrPs.tracts into mice expressing the same type of mutated
Pathological consequences may result from overex-PrP at a low level, which does not cause spontaneous
pression of a normal protein in the tissue in which it isdisease, but the disease could not be transmitted to
normally expressed (Xu et al., 1993; Simson et al., 1994;wild-type mice (Hsiao et al., 1994; Telling et al., 1996).
Sakata et al., 1996) or from ectopic expression or over-We inoculated mice overexpressing wild-type PrP
expression (McAndrew et al., 1995). Westaway et al.(tga20 mice) with brain extracts from E11 and F11 mice
(1994) reported that (uninoculated) transgenic mice har-taken at 2.5 months of age. No signs of disease were
boring high copy numbers of cosmids containing wild-observed in the indicator mice as late as 60 weeks after
type PrP genes developed truncalataxia, hindlimb paral-inoculation. Further attempts of transmission into mice
ysis, and tremors as well as necrotizing myopathy ofexpressing PrP with 32±121 or 32±134 deletions at low
skeletal muscle, demyelinating polyneuropathy and fo-levels are required in view of the reports mentioned
above (Hsiao et al., 1994; Telling et al., 1996). cal vacuolation of the central nervous system. Disease
Cell
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Figure 7. Time Course of Neuropathological Changes in the Internal Cerebellar Granular Layer of F11 Transgenic Mice
Sections were immunostained for GFAP. At 3 weeks (B) and 4 weeks (C) of age, the internal granular layer is still largely intact and similar to
the nontransgenic Prnpo/o control (A), but incipient astrogliosis is observed. In 5-week-old mice (D), there is prominent diffuse astrogliosis of
the whole cerebellar cortex and coarse vacuolation of the granular cell layer. Several apoptotic figures are visible in the granular cell layer.
At 6 (E) and 8 (F) weeks, the granular layer has collapsed and shows progressive cell loss as well as extreme gliosis. The Purkinje cells appear
intact throughout this process. (G and H) GFAP immunohistochemistry of the cerebellum of mice carrying the E11 transgene cluster on a
Prnpo/o (H) or on a tga20 genetic background (G). Introduction of the wild-type transgenes completely abrogated the phenotype seen in E11
transgenic mice, as demonstrated here by the absence of astrogliosis (G).
developed late in life, between 460 and 650 days of intron 2 (for an exact description, see Fischer et al.,
1996), although expressing at least a similar level of PrP,age, depending on transgene dosage. Transgenic mice
overexpressing PrP from multiple copies of a mouse never showed any disabilities, perhaps because they
had a different expression pattern (Fischer et al., 1996)PrP (B allele) cosmid (obtained from S. Prusiner) were
generated in our laboratory and showed the same phe- or a different PrP sequence.
A different heritable disorder was observed in wild-notype; however, tga20 mice carrying a minitransgene
encoding the Prnpa allele coding sequence and lacking type mice overexpressing a mouse±hamster hybrid PrP
Pathogenic Effect of Truncated PrP
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Table 1. Wild-Type Prnp Alleles Protect against Deleterious Effects of Truncated Prnp Allelesa
Cross Parents Genotype of Offspring Phenotype
1 E11/2, Prnpo/o E11/2, tga20/2, Prnpo/o 1 killed at 11 weeks (healthy)b
3 tga20/2, Prnpo/o 1 killed at 15 weeks (healthy)c
1 healthy at 52 weeks
2 F11/2, Prnpo/o F11/2, Prnp1/o 2 healthy at 31±32 weeks
3 Prnp1/o 1 killed at 12 weeks (healthy)b
3 F11/2, Prnp1/o F11/2, Prnp1/1 1 killed at 11 weeks (healthy)b
3Prnp1/o
4 F11/2, Prnp1/o F11/2, Prnp1/o 4 healthy at 22±23 weeks
3 Prnpo/o F11/2, Prnpo/o 11 sick at 5±9 weeks
5 F11/2, Prnpo/o F11/2, tga20/2, Prnpo/o 2 killed at 14 weeks (healthy)b
3 tga20/tga20, Prnpo/o 5 healthy at 31±32 weeks
6 F11/2, tga20/2, Prnpo/o F11/2, tga20/2, Prnpo/o 1 healthy at 23 weeks
3 Prnpo/o F11/2, Prnpo/o 1 sick at 6 weeks
7 F11/2, tga20/2, Prnpo/o F11/2, tga20/2, Prnpo/o 6 healthy at 19 weeks
3 tga20/2, Prnpo/o F11/2, Prnpo/o 3 sick at 6±7 weeks
8 F11/2, tga20/2, Prnpo/o F11/2, C4/2, Prnpo/o 1 healthy at 24 weeks
3 C4/C4, Prnpo/o F11/2, C4/2, tga20/2, Prnpo/o 1 healthy at 24 weeks
9 F35/2, Prnpo/o F35/2, Prnpo/o 5 healthy at 29 weeks
3 Prnp1/1
a C4, E11, F11, and F35 designate the truncated PrP transgene clusters present in C4, E11, F11, and F35 mice, respectively (see Figure 1C).
tga20 is a gene cluster encoding wild-type PrP. Alleles encoding wild-type PrP are in bold type.
b Western blots of brain extracts showed transgene expression levels similar to those of the same transgene on a Prnpo/o background (see
Figure 2d).
c Histology of the brain was normal.
with a deletion between residues 177 and 200 or 201 related to it at the DNA sequence level) (Figure 8). This
and 217, which disrupted the penultimate and last a would explain why ablation of PrP has no obvious phe-
helix (Riek et al., 1997), respectively (Muramoto et al., notypic consequences. We postulate that truncated PrP
1997). These mice showed cytoplasmic inclusions of can interact with Lprp without giving rise to a signal and
PrP-derived deposits in neurons and spontaneously de- that it can compete efficiently with p, thus acting as an
veloped fatal CNS illnesses similar to neuronal storage inhibitor of the latter. Because the pathogenic effects
diseases at ages ranging mostly from 90 to 227 days. of truncated PrP are overcome by coexpression of wild-
The behaviorally challenged transgenic mice described type PrP at comparable levels, the affinity of Lprp for
in this paper differ from the mice described by Prusiner truncated PrP would have to be less than for intact PrP
and his colleagues in several regards. (1) They exhibit but greater than for p. It is interesting to note that the
the pathological phenotype even when expressing trun- detrimental effects of PrP appear when the truncations
cated PrP at only about twice wild-type levels. (2) The extend to or beyond position 121. It has been shown
phenotype is apparent within a few weeks after birth. that mature PrP consists of a flexible, disordered tail
(3) The truncated protein is expressed at the cell surface. extending from position 23 to 120, a highly conserved
(4) The histopathology is essentially restricted to the region, while the remainder is folded into a stable, struc-
cerebellum with degeneration of the granular layer and tured globular part (Donne et al., 1997; Riek et al., 1997).
coarse vacuolation of the white matter and no obvious It is appealing to imagine that the globular domain binds
pathology in cortex or basal ganglia. (5) There were no
to a receptor (or ligand), while the tail is responsible for
PrP-derived deposits.
the activation. Several candidate ligands for PrP have
Strikingly, the pathological phenotype was overcome
been recently suggested (Martins et al., 1997; Rieger etby introducing as few as a singly copy of the wild-type
al., 1997; Yehiely et al., 1997).PrP gene.
The hypothesis presented above suggests that thereHow can our findings be explained?
could exist inherited diseases with phenotypes similarAn unspecific toxic effect is unlikely because only
to the one we have reported, not only as a consequencegranule cells of the cerebellum, with the exception of
of PrP truncations but also of mutationsof the presumedthose in the flocculus that also express PrP, undergo
ligand Lprp or of component(s) of the system transmittingcell death, while other neurons expressing the truncated
the postulated signal. We are not aware of natural mousePrP at similar levels (e.g., in the cortex) do not.
mutations qualifying for this role, but human familialA dominant negative effect, i.e., direct interference of
diseases such as congenital cerebellar granule cell hy-truncated PrP with a function unique to normal PrP,
poplasia and mental retardation (cerebelloparenchymalcannot be invoked because pathology develops in mice
disorder III) (Norman, 1940; McKusick, 1988), primarydevoid of PrP. However, a phenotypic transdominant
degeneration of the granular layer of the cerebellumnegative effect is conceivable. Assume that in wild-type
(Pascual-Castroviejo et al., 1994), or infantile cerebello-mice PrP interacts with a presumed ligand, ªLprpº, to elicit
optic atrophy (PEHO syndrome) (Haltia and Somer,a particular signal and that the same signal is elicited by
1993), all of which present with degeneration of thegran-the interaction of Lprp with p, a conjectural protein that
has the functional properties of PrP (but is not closely ule cell layer, are possible candidates.
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Generation, Identification, and Maintenance
of Transgenic Mice
The pPrPHG plasmids containing the truncated PrP coding se-
quences were propagated in E. coli XL1 blue, the minigene excised
with NotI and SalI, and processed as described (Fischer et al., 1996).
Nuclear injections into fertilized oocyteswere carried out by conven-
tional methods (Brinster et al., 1985; Wilmut et al., 1991). In all but
two cases, zygotes were from Prnpo/o mice (with a 129/Sv-C57BL/6
hybrid background); however, C15 mice were from zygotes resulting
from a cross between Prnpo/o and wild-type C57BL/6 mice and D32
animals from zygotes of a C57BL/6 3 DBA/2 cross. Transgenes on
a Prnpo/o background were identified by PCR using the exon 2 primer
pE21 (59-CAACCGAGCTGAAGCATTCTGCCT) and the exon 3 primer
Mut217 (59-CCTGGGACTCCTTCTGGTACCGGGTGACGC). For breed-
ing out the Prnp1 allele from transgenic mice that had been gener-
ated on a wild-type or Prnp1/o background, PCRanalysis was carried
out using primers RK1 (Prnp intron 2, 59-TCAGCCTAAATACTGG
GCA), RK2 (Prnp exon 3, 59-GCCTAGACCACGAGAATGC), and RK3
(neoR gene, 59-CAAGGGCCCCTCCTCCTAGAA ); RK1and RK2 gave
an 880 bp signal for the Prnp1 allele, and RK1 and RK3 gave a 730
bp product for the Prnpo allele. Semiquantitative determination of
transgene copy number relative to the residue of the PrP knockout
gene was carried out with primers P7, PRP134, and Mut217, ampli-
fying by PCR for 21 cycles using 32P-labeled dATP (Fischer et al.,
1996). Primers P7 (located in the neoR gene within the PrPo allele:
59-TCTATCGCCTTCTTGACGAGTTCTTCTGAG and Mut217 amplify
a Prnpo amplicon of 210 bp, while PRP134 and Mut217 yield a 265
bp fragment characteristic for the wild-type as well as the truncated
alleles.
Northern blot analyses (Sambrook et al., 1989) were performed
on RNA extracted by the acid phenol method (Chomczynski andFigure 8. Model to Explain Effects of Truncated PrP
Sacchi, 1987) using as a PrP probe a randomly 32P-labeled (Prime-PrP is composed of a globular part (dark-hatched polygon) and
it, Stratagene) 308 bp amplicon prepared with primers pMcP5 (exona flexible tail (string-and-ball) (Riek et al., 1997) and may interact
1, 59-GTCGGATCAGCAGACCGATTCTGGGCGCT) and PRP312 onseparately with a presumed ligand, ªLprpº, via these two domains, PrP cDNA. This probe hybridizes with all wild-type and truncatedthereby eliciting a signal. The same signal might be elicited by the
PrP mRNAs as well as the ªreadthroughº RNA from the disruptedinteraction of Lprp with p, a conjectural protein that has the functional Prnp locus (BuÈ eler et al., 1992). After stripping, the sample wasproperties of PrP (top, left), explaining why PrP knockout mice show
rehybridized with a GAPDH probe (Fort et al., 1985).no phenotype (top, right). The model postulates that PrP lacking
For Western blot analyses, a brain hemisphere was homogenizedthe flexible tail can interact with Lprp without giving rise to a signal in 7 vol PBS, 0.5% Nonidet P-40, and 0.5% deoxycholate and theand that it can compete efficiently with p, thus acting as a dominant
solution was centrifuged 10 min in an Eppendorf centrifuge. Forinhibitor of the latter (bottom). The postulated signal could act
deglycosylation, 50 mg denatured protein were incubated at 378Cthrough PrP if the deleterious effect is cell autonomous or through
for 4 hr with 500 U PNGase F (New England Biolabs) according toLprp if it is not. the manufacturer's instructions. To inhibit proteolysis, the inhibitors
Pefabloc (1 mg/ml), Leupeptin (10 mg/ml), Pepstatin (10 mg/ml),
Experimental Procedures Aprotinin (1 mg/ml) (all from Boehringer, Mannheim), and 0.5 mg/ml
EDTA were added. Recombinant PrPs with an N-terminal His tag
PrP Minigenes with Amino-Proximal Deletions were expressed in E. coli (unpublished data) and purified by Ni-
Plasmid PrP12Msc contains a murine PrP cDNA fragment extending chelate affinity chromatography (Petty, 1996). After electrophoresis
from the beginning of the first exon to codon 31 in exon 3 was of protein samples through 12% or 15% SDS-polyacrylamide gels,
prepared by PCR, using as upstream primer pE1[B/T] (59-TGTCGGA samples were transferred to PVDF membranes (Immobilon P, Milli-
TCCAGCAGACCGATTCTGG) and as downstream primer PRP312 pore) and exposed to a rabbit polyclonal anti-PrP antiserum (R340
(59-CCACCCTCCAGGCTTT). This 247 bp fragment was ligated into raised against E. coli murine PrP [1:5000; Brandner et al., 1996], or
pBluescript KS2, which had been cleaved with SacI and blunted; R009 raised against PrP residues 221±234, [1:2000; Barry et al.,
the junction between the downstream end of the PCR product (59- 1988]), then to peroxidase-labeled anti-rabbit antiserum (1:2500;
TGG) and the blunted SacI site (59-CCA) generated an MscI site (59- Amersham) and developed with the ECL detection system (Am-
TGG9CCA). ersham).
PCR products of PrP cDNA starting at codons 94, 107, 122, or
135 were generated using a downstream primer P4 (59-CCTTGGGAA
HistopathologyTGAACAAAGGTTTGCTTTCAAC; third exon) and upstream primers
Organs were fixed in 4% paraformaldehyde inPBS (pH 7.5), paraffin-PRP93 (59-ACCCATAATCAGTGGAACAA), PRP106 (59-AACCTCAA
embedded, and cut into 2 mm sections. Brain sections were stainedGCATGTGGCA), PRP121 (59-GGGGGCCTTGGTGGCTA), and PRP
with hematoxylin-eosin, Luxol-Nissl (myelin and neurons), and with134 (59-AGGCCCATGATCCATTT), respectively, and Pfu polymerase
commercial antibodies to GFAP (glial fibrillary acidic protein; acti-(which produces blunt ends). Each PCR product was cleaved with
vated astrocytes), MAP-2 (dendrites), or synaptophysin (synapses).EcoRI in the 39 noncoding region and ligated into plasmid PrP12Msc
PrP was detected on microwave-treated paraffin sections usingthat had been cleaved with MscI (to give a blunt end after co-
monoclonal antibody 8H4 (hybridoma culture supernatant diluteddon 31) and EcoRI. This yielded plasmids PRP123.C, PRP123.D,
1:100, a kind gift of Dr. Man-Sun Sy) (Zanusso et al., submitted) andPRP123.E, and PRP123.F with deletions of codons 32±93, 32±106,
visualized using the peroxidase-anti-peroxidase method.32±121, and 32±134, respectively.
Finally, the KpnI-EcoRI fragment of pPrPHG (Fischer et al., 1996)
Acknowledgmentswas replaced by the KpnI-EcoRI fragment of each of the PRP123
plasmids to yield plasmids pPrPHG.C, pPrPHG.D, pPrPHG.E, and
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